Theresa Hahn

Theresa Hahn

UNVERIFIED PROFILE

Are you Theresa Hahn?   Register this Author

Register author
Theresa Hahn

Theresa Hahn

Publications by authors named "Theresa Hahn"

Are you Theresa Hahn?   Register this Author

100Publications

2474Reads

8Profile Views

gwasurvivr: an R package for genome-wide survival analysis.

Bioinformatics 2019 Jun;35(11):1968-1970

Division of Pharmacy Practice and Science, College of Pharmacy, The Ohio State University, Columbus, OH, USA.

View Article

Download full-text PDF

Source
https://academic.oup.com/bioinformatics/advance-article/doi/
Publisher Site
http://dx.doi.org/10.1093/bioinformatics/bty920DOI Listing
June 2019

Methods to prevent and treat relapse after hematopoietic stem cell transplantation with tyrosine kinase inhibitors, immunomodulating drugs, deacetylase inhibitors, and hypomethylating agents.

Bone Marrow Transplant 2019 04 23;54(4):497-507. Epub 2018 Jul 23.

Stem Cell Transplant Program, University Hospital Cleveland Medical Center, Case Western Reserve University, Cleveland, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41409-018-0269-3
Publisher Site
http://dx.doi.org/10.1038/s41409-018-0269-3DOI Listing
April 2019

Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors.

Haematologica 2019 Apr 31;104(4):844-854. Epub 2018 Oct 31.

Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI.

View Article

Download full-text PDF

Source
http://www.haematologica.org/lookup/doi/10.3324/haematol.201
Publisher Site
http://dx.doi.org/10.3324/haematol.2018.200121DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442962PMC
April 2019

Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study.

Biol Blood Marrow Transplant 2019 04 10;25(4):699-711. Epub 2018 Nov 10.

Center for International Blood and Marrow Transplant Research, Minneapolis, Minnesota; National Marrow Donor Program/Be the Match, Minneapolis, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.11.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6453753PMC
April 2019

BPX-501 T cells interfere with minimal residual disease evaluation of B-cell acute lymphoblastic leukemia.

Bone Marrow Transplant 2018 05 17;53(5):651-653. Epub 2018 Jan 17.

Department of Medicine, Blood and Marrow Transplant Program, Roswell Park Cancer Institute, Buffalo, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-017-0036-xDOI Listing
May 2018

Financial Hardship after Hematopoietic Cell Transplantation: Lack of Impact on Survival.

Cancer Epidemiol Biomarkers Prev 2018 03 13;27(3):345-347. Epub 2018 Feb 13.

Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-17-1040DOI Listing
March 2018

Bone remodeling and regulating biomarkers in women at the time of breast cancer diagnosis.

Breast Cancer Res Treat 2017 02 3;161(3):501-513. Epub 2016 Dec 3.

Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-016-4068-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5243170PMC
February 2017

Quantifying MHC dextramer-induced NFAT activation in antigen-specific T cells as a functional response parameter.

Methods 2017 01 17;112:75-83. Epub 2016 Jun 17.

Department of Flow and Image Cytometry, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ymeth.2016.06.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5821144PMC
January 2017

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Research Methodology and Study Design Working Group Report.

Biol Blood Marrow Transplant 2017 01 30;23(1):10-23. Epub 2016 Aug 30.

Institute for Cancer Outcomes and Survivorship, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.08.018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5182148PMC
January 2017

Decreased risk of cancer in multiple sclerosis patients and analysis of the effect of disease modifying therapies on cancer risk.

J Neurol Sci 2016 Nov 9;370:13-17. Epub 2016 Sep 9.

Jacobs Comprehensive MS Treatment and Research Center, University at Buffalo, Buffalo, NY, USA; New York State MS Consortium, University at Buffalo, Buffalo, NY, USA; Department of Neurology, State University of New York at Buffalo, Buffalo, NY, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jns.2016.09.005DOI Listing
November 2016

Financial Hardship and Patient-Reported Outcomes after Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant 2016 08 13;22(8):1504-1510. Epub 2016 May 13.

Division of Hematologic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.05.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949125PMC
August 2016

Early versus late preemptive allogeneic hematopoietic cell transplantation for relapsed or refractory acute myeloid leukemia.

Biol Blood Marrow Transplant 2014 Sep 24;20(9):1369-74. Epub 2014 May 24.

Department of Medicine, BMT Program, Roswell Park Cancer Institute, Buffalo, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.05.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292802PMC
September 2014

Strategies for induction, autologous hematopoietic stem cell transplantation, consolidation, and maintenance for transplantation-eligible multiple myeloma patients.

Hematology Am Soc Hematol Educ Program 2013 ;2013:496-503

1Roswell Park Cancer Institute, BMT Program, Department of Medicine, Buffalo, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2013.1.496DOI Listing
July 2014

Simplified validated prognostic model for progression-free survival after autologous transplantation for hodgkin lymphoma.

Biol Blood Marrow Transplant 2013 Dec 3;19(12):1740-4. Epub 2013 Oct 3.

Division of Blood and Marrow Transplant, Roswell Park Cancer Institute, Buffalo, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2013.09.018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906436PMC
December 2013

Unrelated donor allogeneic hematopoietic cell transplantation is underused as a curative therapy in eligible patients from the United States.

Biol Blood Marrow Transplant 2013 Oct 25;19(10):1459-64. Epub 2013 Jun 25.

Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2013.06.014DOI Listing
October 2013

Prevalence of hematopoietic cell transplant survivors in the United States.

Biol Blood Marrow Transplant 2013 Oct 30;19(10):1498-501. Epub 2013 Jul 30.

National Marrow Donor Program, Minneapolis, Minnesota; Center for International Blood and Marrow Transplant Research, Minneapolis, Minnesota. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2013.07.020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3779514PMC
October 2013

Managing cardiac amyloidosis: auto or allotransplant?

Am J Hematol 2011 Oct;86(10):885-6

Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajh.22133
Publisher Site
http://dx.doi.org/10.1002/ajh.22133DOI Listing
October 2011

Self-determinism: alloBMT for AML.

Blood 2011 Feb;117(7):2080-1

Roswell Park Cancer Institute, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2010-12-325340DOI Listing
February 2011

Accelerated bone mineral density loss occurs with similar incidence and severity, but with different risk factors, after autologous versus allogeneic hematopoietic cell transplantation.

Biol Blood Marrow Transplant 2010 Aug 24;16(8):1130-7. Epub 2010 Feb 24.

Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York 14263, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2010.02.017DOI Listing
August 2010

Outcomes of hematologic malignancies after unrelated donor hematopoietic cell transplantation according to place of residence.

Biol Blood Marrow Transplant 2010 Mar 30;16(3):368-75. Epub 2009 Oct 30.

Section of Hematology/Oncology, Department of Internal Medicine, University of Nebraska Medical Center, 987680 Nebraska Medical Center, Omaha, NE 68198-7680, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2009.10.028DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2822013PMC
March 2010

Human leukocyte antigen DR4 is associated with inferior progression-free survival following allogeneic hematopoietic stem cell transplantation for lymphoid malignancies.

Leuk Lymphoma 2008 Aug;49(8):1494-500

Department of Medicine, School of Medicine and Biochemical Sciences, State University of New York at Buffalo, Buffalo, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190802158453DOI Listing
August 2008

Ganciclovir inhibits lymphocyte proliferation by impairing DNA synthesis.

Biol Blood Marrow Transplant 2007 Jul 7;13(7):765-70. Epub 2007 May 7.

Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York 14202, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2007.03.009DOI Listing
July 2007

Quantitative diffusion tensor imaging detects dopaminergic neuronal degeneration in a murine model of Parkinson's disease.

Neurobiol Dis 2007 Jun 6;26(3):590-6. Epub 2007 Mar 6.

Center for Neurovirology and Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, NE 68198-1045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nbd.2007.02.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2040046PMC
June 2007

HLA DR15 and immunobiologic outcomes.

Biol Blood Marrow Transplant 2007 Mar;13(3):371

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2006.12.439DOI Listing
March 2007

Excess diagnosis of non-Hodgkin's lymphoma during spring in the USA.

Leuk Lymphoma 2007 Feb;48(2):357-66

Division of Chronic Disease Epidemiology, Department of Epidemiology and Public Health, Yale School of Medicine, New Haven, CT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190601076799DOI Listing
February 2007

Human leukocyte antigen (HLA) DR15 is associated with reduced incidence of acute GVHD in HLA-matched allogeneic transplantation but does not impact chronic GVHD incidence.

Blood 2006 Mar 10;107(5):1970-3. Epub 2005 Nov 10.

Department of Medicine and Laboratory Medicine, Blood and Marrow Transplantation, Roswell Park Cancer Institute, Buffalo, NY 14202, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2005-05-1958DOI Listing
March 2006

Arterial thrombosis in four patients treated with thalidomide.

Leuk Lymphoma 2005 Feb;46(2):239-42

Albany College of Pharmacy, NY 12208, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190400015675DOI Listing
February 2005